Cystic Fibrosis Study Planned for Adults with Diabetes and Liver Disease
Cystic Fibrosis, News
ProMetic Life Sciences Inc., a biopharmaceutical company developing bioseparations, plasma-derived therapeutics and small-molecule therapies, announced this week that it is planning to commence a Phase 2 double-blind, placebo-controlled clinical trial of its ... Read more